XEVUDY Trademark

Trademark Overview

On Tuesday, February 2, 2021, a trademark application was filed for XEVUDY with the United States Patent and Trademark Office. The USPTO has given the XEVUDY trademark a serial number of 90505394. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, May 28, 2024. This trademark is owned by Glaxo Group Limited. The XEVUDY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for treatment or prevention of COVID-19, coronavirus disease and respiratory diseases and disorders; vaccines for prevention of COVID-19, coronavirus disease
xevudy

General Information

Serial Number90505394
Word MarkXEVUDY
Filing DateTuesday, February 2, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, May 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 5, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for treatment or prevention of COVID-19, coronavirus disease and respiratory diseases and disorders; vaccines for prevention of COVID-19, coronavirus disease
Translation of Words in MarkThe wording "XEVUDY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Thursday, May 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 5, 2021NEW APPLICATION ENTERED
Monday, August 30, 2021ASSIGNED TO EXAMINER
Monday, August 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 5, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 30, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 13, 2022SOU TEAS EXTENSION RECEIVED
Friday, May 13, 2022SOU EXTENSION 1 FILED
Friday, May 13, 2022SOU EXTENSION 1 GRANTED
Tuesday, May 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 9, 2022SOU TEAS EXTENSION RECEIVED
Friday, September 9, 2022SOU EXTENSION 2 FILED
Friday, September 9, 2022SOU EXTENSION 2 GRANTED
Tuesday, September 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 16, 2022ASSIGNED TO EXAMINER
Thursday, May 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 25, 2023SOU EXTENSION 3 FILED
Thursday, May 25, 2023SOU EXTENSION 3 GRANTED
Saturday, May 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 27, 2023SOU EXTENSION 4 FILED
Monday, November 27, 2023SOU EXTENSION 4 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 28, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 28, 2024SOU EXTENSION 5 GRANTED
Tuesday, May 28, 2024SOU EXTENSION 5 FILED
Wednesday, May 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

xevudy coronavirus disease prevention covid diseases disorders vaccines respiratory preparations pharmaceutical